|Page (1) of 1 - 10/12/17||email article||print page|
(October 12, 2017)
FARMINGDALE, N.Y., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will participate in the 2017 North American Spine Society (“NASS”) 32nd Annual Meeting to be held at the Orange County Convention Center in Orlando, Florida from October 25 -28, 2017.
Stavros Vizirgianakis, chief executive officer of Misonix, will deliver an analyst presentation on Wednesday, October 25 at 3:30 pm ET at the Misonix booth - #765 – to review the company’s technology, products, and corporate developments.
The North American Spine Society (“NASS”) is a global multidisciplinary medical society that utilizes education, research and advocacy to foster the highest quality, ethical,? value- and evidence-based spine care for patients.
About MisonixMisonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $1.5 billion annually; Misonix's proprietary ultrasonic medical devices are used in spine surgery, neurosurgery, orthopedic surgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.
Safe Harbor Statement
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter